Roche is a publicly listed company tracked for investment-relevant business developments.
Roche is scaling Nvidia AI infrastructure massively — tripling to over 3,500 Blackwells across US/EU — and embedding AI across the full value chain: Genentech's lab-in-the-loop drug discovery (BioNeMo), manufacturing digital twins (Omniverse), and large-scale genomics diagnostics (Parabricks), signaling deep enterprise commitment to AI-native R&D.